期刊文献+

化疗相关性腹泻发生时间的相关因素分析 被引量:10

Analysis of Related Factors of Chemotherapy-induced Diarrhea:A Report of 68 Cases
在线阅读 下载PDF
导出
摘要 目的:探讨消化道肿瘤以5-FU为基础的联合化疗方案引起化疗相关性腹泻(Chemotherapy-induced diarrhea,CID)发生时间的相关因素。方法:测定CID患者的菌群分布,记录并分析年龄、性别、体质状况评分、肿瘤类型、临床分期、不同化疗方案、腹泻发生时间、腹泻程度等临床资料。结果:CID发生率为6.33%。CID患者有76.47%发生菌群失调,68例CID患者男43例,女25例;平均年龄53.93岁。PS评分:0分9例,1分7例,2分24例,3分25例,4分3例。肿瘤类型:结肠癌21例,胃癌18例,食道-贲门癌13例,肝癌4例,胰腺癌3例,十二指肠癌2例,胆囊癌2例,直肠癌5例。腹泻发生时间最短0d,最长62d,平均10.13d。化疗方案:FOLFIRI方案20例,FORFOX方案9例,DLF方案4例,TDLF方案5例,HDLF方案16例,NDLF方案9例。GDLF方案5例。腹泻发生程度:Ⅰ度1例,Ⅱ度6例,Ⅲ度60例,Ⅳ度1例。结论:CID患者绝大部分发生菌群失调,不同体质状况评分、不同化疗方案影响CID发生时间,而年龄、性别、肿瘤类型、临床分期、不影响CID发生时间。 Objective:To discuss the retated factors of chemotherapy- induced diarrhea during combination Chemotherapy based on 5 - FU for digestive tract carcinoma. Methods: In 68 CID patients, the flora disturbance was determined, the clinical data including age, sex, PS score, tumor type, clinical stage, different chemotherapy regimens,occuring time and degree of diarrhea, were recorded and analysed. Results:The incidence of CID was 6.33 %. 76.47 % of these patients had flora imbalance. Among 68 CID patients, 43 patients were males and 25 females,the average age was 53.93 years old ,PS score was o in 9 patients,1 in 7 ones,2 in 24 ones,3 in 25 ones and 4 in 3 ones. There were 21 patients with colonic tumor, 18 with gastric tumor, 13 with esophageal - cardia tumor,4 with liver tumor,3 with pancreatic tumor,2 with duodenal tumor,2 with gallbladder tumor and 5 with rectal tumor. The average duration of diarrhea was 10.13 days (range,o to 62 days). 20 patients received FOLFIRI regimen, 9 received FORFOX regimen, 4 received DLF regimen, 5 received TDLF regimen, 16 received HDLF regimen,9 received NDLF regimen and 5 received GDLF regimen. The degree of dirrhea was Ⅰ in 1 patient, Ⅱ in 6 patients, Ⅲ in 60 patients and Ⅳ in 1 patient. Conclusion:Most CID patients have flora imbalance. PS score and chemotherapy regimens are related with age, sex and tumor type. Clinical stage are not velated to CID
出处 《内蒙古医学杂志》 2005年第11期998-1000,共3页 Inner Mongolia Medical Journal
关键词 化疗相关性腹泻 相关因素 Chemotherapy - induced diarrhea Related factor
  • 相关文献

参考文献5

  • 1Kornblan S, Benin AB, Catalano R, et al, Management of cancertreatment - related diarrhea : issue and therapeutic st rategies[J]. J Pain and Symptom Management,2000,19(2):118.
  • 2姜之馨,邱立华,朱晓代.去甲万古霉素治疗化疗相关性腹泻的临床研究[J].中华内科杂志,2003,42(12):869-870. 被引量:6
  • 3Boige V, creux M. Prevention and treatment of chemotherapy induced digestive toxieities[J]. Bull Cancer, 2001,88:163.
  • 4Kahn ME, Senderowicz A, SausviUe EA, et al. Possible mechanism of diarrhe',d side effects associated with the use of a novel chemo-therapeutic agent, flavopiridol[J]. Clin Cancer Res, 2001,7 : 343.
  • 5Innocenti F,Stadler WM, lyer L, et al. Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea [J].Clin Cancer Res, 2000,6 : 3400.

共引文献5

同被引文献85

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部